You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroimmunology

Showing 1 - 25 of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Relapsing-Remitting Trial in Munich, Mainz, Münster (Vivomixx®, Conjugated linoleic acid (CLA/Tonalin® FFA

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Vivomixx®
  • +3 more
  • Munich, Bavaria, Germany
  • +2 more
Jun 15, 2023

Rare Neuroimmunologic Disorders

Recruiting
  • Neuromyelitis Optica
  • +3 more
    • Dallas, Texas
      The University of Texas Southwestern Medical Center
    May 9, 2022

    Relapsing-remitting Multiple Sclerosis Trial in Berlin (epigallocatechin-gallate (Sunphenon), )

    Completed
    • Relapsing-remitting Multiple Sclerosis
    • epigallocatechin-gallate (Sunphenon)
    • placebo
    • Berlin, Germany
    • +1 more
    Jul 28, 2021

    Multiple Sclerosis, Quality of Life, Patient Empowerment Trial in Spain (Multiple Sclerosis Expert Patient Program of Catalonia)

    Recruiting
    • Multiple Sclerosis
    • +5 more
    • Multiple Sclerosis Expert Patient Program of Catalonia
    • Barcelona, Spain
    • +4 more
    Dec 10, 2021

    Acute Optic Neuritis Network:International Study That

    Recruiting
    • Demyelinating Diseases
    • +4 more
    • non-interventional study
    • Aurora, Colorado
    • +25 more
    Oct 31, 2022

    Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

    Recruiting
    • Relapsing Multiple Sclerosis
    • +2 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • Best Available Therapy (BAT)
    • Palo Alto, California
    • +20 more
    Jan 25, 2023

    Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme

    Completed
    • Fabry Disease
    • +2 more
      • Buenos Aires, Argentina
      • +8 more
      Apr 8, 2021

      Suboptimally Controlled Participants Previously Taking Oral or

      Recruiting
      • Multiple Sclerosis
      • Cladribine Tablets
      • Cullman, Alabama
      • +66 more
      Nov 29, 2022

      Neurological Immune-related Adverse Events

      Recruiting
      • Neurological Disease
      • Analysis of biomarkers and their correlation with clinical characteristics and outcome
      • Bron, France
        Centre de référence des syndromes neurologiques paranéoplasiques
      Jul 28, 2023

      Egyptian Patients With Neuromyelitis Optica Spectrum Disorder

      Not yet recruiting
      • Assessment of Serum FAM19A5level in Egyptian Patients With NMOSD
      • serum level of FAM19A5
      • (no location specified)
      Jul 4, 2022

      Multiple Sclerosis (MS) Trial in Basel, Luzern 16, Rheinfelden (Neurostatus-SMARTCARE, Standard Neurostatus-EDSS)

      Recruiting
      • Multiple Sclerosis (MS)
      • Neurostatus-SMARTCARE
      • Standard Neurostatus-EDSS
      • Basel, Switzerland
      • +2 more
      Jan 2, 2023

      Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

      Not yet recruiting
      • Multiple Sclerosis
      • +2 more
      • KYV-101 anti-CD19 CAR-T cell therapy
      • Standard lymphodepletion regimen
      • Palo Alto, California
        Stanford Multiple Sclerosis Center
      Nov 13, 2023

      Relapsing Remitting Multiple Sclerosis Trial in Milan (Fingolimod, Dimethyl Fumarate)

      Terminated
      • Relapsing Remitting Multiple Sclerosis
      • Milan, Italy
        Fondazione IRCCS Istituto Neurologico C. Besta, Neuroimmunology
      Oct 29, 2019

      Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City

      Recruiting
      • Secondary Progressive Multiple Sclerosis
      • +2 more
      • Ferumoxytol infusion
      • +2 more
      • Salt Lake City, Utah
        University of Utah Health Imaging and Neurosciences Center
      Jun 22, 2022

      Neuroimmunological Diseases of the Central Nervous System

      Recruiting
      • Central Nervous System Disease
      • Multiple Sclerosis
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 24, 2022

        Magnetic Resonance Imaging to Evaluate Activity of Multiple

        Recruiting
        • Multiple Sclerosis
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 30, 2023

          Multiple Sclerosis Trial in Cambridge (Metformin and clemastine in combination, Placebo)

          Recruiting
          • Multiple Sclerosis
          • Metformin and clemastine in combination
          • Placebo
          • Cambridge, United Kingdom
            Addenbrooke's Hospital
          Jun 14, 2022

          Biological Samples From Patients With Rare Neurological Diseases

          Recruiting
          • Nervous System Diseases
          • Blood collection on admission and longitudinally
          • Toulouse, France
            Purpan University Hospital
          May 17, 2022

          Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome Trial in Hamburg (Understanding MRI in

          Active, not recruiting
          • Multiple Sclerosis
          • +2 more
          • Understanding MRI in MS (website)
          • Control website
          • Hamburg, Germany
            University Medical Centre Hamburg-Eppendorf
          Dec 5, 2022

          X-linked Adrenoleukodystrophy Trial in Palo Alto (vitamin D3)

          Completed
          • X-linked Adrenoleukodystrophy
          • vitamin D3
          • Palo Alto, California
            Stanford University
          Jun 6, 2022

          Multiple Sclerosis Trial in Basel (DreaMS)

          Completed
          • Multiple Sclerosis
          • DreaMS
          • Basel, Switzerland
            RC2NB
          Mar 1, 2021

          Vitiligo Trial in Trento (Psychodramatic psychotherapy, Self-help activities)

          Not yet recruiting
          • Vitiligo
          • Psychodramatic psychotherapy
          • Self-help activities
          • Trento, Italy
            APSS Trento
          Aug 11, 2023

          Multiple Sclerosis Trial run by the NINDS (Anakinra)

          Recruiting
          • Multiple Sclerosis
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 20, 2023

          Quick Contrast Sensitivity Function Method in Healthy Controls

          Unknown status
          • Multiple Sclerosis
            • Hamburg, Germany
              Institute of Neuroimmunology and MS
            Oct 18, 2018

            Multiple Sclerosis Trial (Injection of autologous bone marrow derived mesenchymal stem cells)

            Completed
            • Multiple Sclerosis
            • Injection of autologous bone marrow derived mesenchymal stem cells
            • (no location specified)
            Mar 24, 2021